Tag:
Claris Lifesciences
Latest Headlines
Latest Headlines
Updated: Claris says it satisfied FDA in plant inspection, awaits final word
After two years of having products blocked by the FDA, Claris Lifesciences says it has passed an audit and is awaiting word on whether it will again be able to ship to the U.S.
Report: Big Pharma finds Indian collaborations costly
Big Pharma is getting bitten by its deals with Indian generics-makers. One recent example, of course, is Japan's Daiichi Sankyo, which last month felt tremors from Indian unit Ranbaxy as the latter
Hardball warning to Claris defines CMO role
The mysterious and insightful columnist known only as QA Pharm ponders the FDA's intent in the Claris swirling-mass warning letter . The warning may be an indication of the regulator's ongoing
Claris warned over "swirling mass" in antibiotic
A U.S. distributor's report to manufacturer Claris Lifesciences of a "swirling mass" in IV bags of antibiotic Metronidazole has culminated in an FDA warning letter. CEO Arjun Handa received the
Claris antibiotics recalled due to mold contamination
Another day, another recall: India-based Claris Lifesciences is recalling "to the user level" antibiotic and anti-nausea drugs following reports of floating matter in IV bags. The recalls follow by
